Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection

Four decades have passed since the first usage of the therapeutic vaccine in patients with chronic hepatitis B (CHB). However, there is no approved regimen of vaccine therapy for the treatment of CHB. This is mainly attributable to faulty conception, an improper understanding of the cellular and mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbar, Sheikh Mohammad Fazle, Mahtab, Mamun Al, Khan, Sakirul, Yoshida, Osamu, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612083/
https://www.ncbi.nlm.nih.gov/pubmed/36298512
http://dx.doi.org/10.3390/vaccines10101644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612083/
https://www.ncbi.nlm.nih.gov/pubmed/36298512
http://dx.doi.org/10.3390/vaccines10101644

Ejemplares similares